222 related articles for article (PubMed ID: 8394448)
21. Entry of rotaviruses is a multistep process.
Méndez E; López S; Cuadras MA; Romero P; Arias CF
Virology; 1999 Oct; 263(2):450-9. PubMed ID: 10544117
[TBL] [Abstract][Full Text] [Related]
22. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.
Zhou YJ; Burns JW; Morita Y; Tanaka T; Estes MK
J Virol; 1994 Jun; 68(6):3955-64. PubMed ID: 7514681
[TBL] [Abstract][Full Text] [Related]
23. Preparation and characterization of a neutralizing monoclonal antibody directed to VP4 of rotavirus strain K8 which has unique VP4 neutralization epitopes.
Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
Arch Virol; 1991; 121(1-4):153-62. PubMed ID: 1722090
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Sialic Acid-Independent Simian Rotavirus Mutants in Viral Infection and Pathogenesis.
Yamasaki M; Kanai Y; Wakamura Y; Kotaki T; Minami S; Nouda R; Nurdin JA; Kobayashi T
J Virol; 2023 Jan; 97(1):e0139722. PubMed ID: 36602365
[TBL] [Abstract][Full Text] [Related]
25. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.
Dormitzer PR; Greenberg HB; Harrison SC
J Virol; 2001 Aug; 75(16):7339-50. PubMed ID: 11462006
[TBL] [Abstract][Full Text] [Related]
26. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
Alfajaro MM; Kim JY; Barbé L; Cho EH; Park JG; Soliman M; Baek YB; Kang MI; Kim SH; Kim GJ; Park SI; Pendu JL; Cho KO
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243129
[TBL] [Abstract][Full Text] [Related]
27. Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins.
Trask SD; Dormitzer PR
J Virol; 2006 Nov; 80(22):11293-304. PubMed ID: 16971442
[TBL] [Abstract][Full Text] [Related]
28. Rotavirus capsid protein VP5* permeabilizes membranes.
Denisova E; Dowling W; LaMonica R; Shaw R; Scarlata S; Ruggeri F; Mackow ER
J Virol; 1999 Apr; 73(4):3147-53. PubMed ID: 10074166
[TBL] [Abstract][Full Text] [Related]
29. Effect of the selection pressure with anti-VP7 and anti-VP4 neutralizing monoclonal antibodies on reassortant formation between two human rotaviruses.
Kobayashi N; Taniguchi K; Urasawa T; Urasawa S
Arch Virol; 1994; 135(3-4):383-96. PubMed ID: 7802855
[TBL] [Abstract][Full Text] [Related]
30. Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.
Chen DY; Estes MK; Ramig RF
J Virol; 1992 Jan; 66(1):432-9. PubMed ID: 1370090
[TBL] [Abstract][Full Text] [Related]
31. A neutralizing monoclonal antibody to bovine rotavirus VP8 neutralizes rotavirus infection without inhibiting virus attachment to MA-104 cells.
Lee J; Babiuk LA; Yoo D
Can J Vet Res; 1998 Jan; 62(1):63-7. PubMed ID: 9442942
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.
Dunn SJ; Fiore L; Werner RL; Cross TL; Broome RL; Ruggeri FM; Greenberg HB
Arch Virol; 1995; 140(11):1969-78. PubMed ID: 7503695
[TBL] [Abstract][Full Text] [Related]
33. Serum-neutralizing antibody to VP4 and VP7 proteins in infants following vaccination with WC3 bovine rotavirus.
Ward RL; Knowlton DR; Greenberg HB; Schiff GM; Bernstein DI
J Virol; 1990 Jun; 64(6):2687-91. PubMed ID: 2159538
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the interaction between VP8 of bovine rotavirus C486 and cellular components on MA-104 cells and erythrocytes.
Lee J; Yoo D; Redmond MJ; Attah-Poku SK; van den Hurk JV; Babiuk LA
Can J Vet Res; 1998 Jan; 62(1):56-62. PubMed ID: 9442941
[TBL] [Abstract][Full Text] [Related]
35. Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1.
Fleming FE; Graham KL; Taniguchi K; Takada Y; Coulson BS
Arch Virol; 2007; 152(6):1087-101. PubMed ID: 17318737
[TBL] [Abstract][Full Text] [Related]
36. Virus-like particle-induced fusion from without in tissue culture cells: role of outer-layer proteins VP4 and VP7.
Gilbert JM; Greenberg HB
J Virol; 1997 Jun; 71(6):4555-63. PubMed ID: 9151849
[TBL] [Abstract][Full Text] [Related]
37. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.
Kirkwood CD; Bishop RF; Coulson BS
Arch Virol; 1996; 141(3-4):587-600. PubMed ID: 8645097
[TBL] [Abstract][Full Text] [Related]
38. Visualization of Calcium Ion Loss from Rotavirus during Cell Entry.
Salgado EN; Garcia Rodriguez B; Narayanaswamy N; Krishnan Y; Harrison SC
J Virol; 2018 Dec; 92(24):. PubMed ID: 30258012
[TBL] [Abstract][Full Text] [Related]
39. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.
Dormitzer PR; Sun ZY; Wagner G; Harrison SC
EMBO J; 2002 Mar; 21(5):885-97. PubMed ID: 11867517
[TBL] [Abstract][Full Text] [Related]
40. Production and characterization of VP4/VP7 reassortant swine rotaviruses derived from Gottfried and OSU parental strains.
Hesse RA; Couture LP; Ellsworth SR; Duhamel GE; Lu W; Dickinson EO; Benfield DA
Am J Vet Res; 1993 Oct; 54(10):1623-9. PubMed ID: 8250387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
